Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 29, 2022
ValGenesis, Inc and LifeBee have partnered to deliver business consulting and innovative digital validation solutions in GxP regulated areas such as manufacturing, quality assurance,
read more
Thursday, November 10, 2022
Celerion is expanding its molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the development of new gene and cell therapies.
read more
Wednesday, September 21, 2022
Alliance Pharma hired four new leaders, bringing on a new Chief Operating Officer (COO), Chief Commercial Officer (CCO), Chief Financial Officer (CFO), and Chief People Officer (CPO). These leaders will support continued global expansion, which ...
read more
ImaBiotech Group announced the creation of an innovative global bioanalytical CRO with Pyxant Labs Inc. Colorado Springs and Salt Lake City sites. The integration of the expertise, innovation and analytical platforms of the companies to form a ...
read more
Akoya Biosciences Inc. and The Spatial Biology Company® announced a collaboration with AstraZeneca to advance new multiplex immunofluorescence (mIF) workflows and spatial biomarker signatures, based on Akoya’s Phenoptics™ platform. The agreement ...
read more
Algorics, a provider of biostatistics and programming solutions for the pharmaceutical and biotechnology industry, acquired Domain Clinical Data Sciences "DCDS", a clinical data services organization based in India.
read more
Eurofins Technologies announces the launch of its GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 Variants of Concern including B.1.617 (“India”), B.1.427/B.1.429 (“California/USA”), B.1.351 (“South Africa”) ...
read more
The agreement with the U.S. Department of Health and Human Services, in coordination with the U.S. Department of Defense (DOD), will expand testing opportunities in K-8 schools, underserved populations and congregate settings such as homeless ...
read more
Tuesday, November 24, 2020
Isohelix announced its GeneFiX Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics.
read more
Friday, November 20, 2020
ADVAITE announced the company's high complexity CLIA laboratory operating out of Chicago, IL has been authorized to offer Yale University's SalivaDirect test.
read more
Friday, November 20, 2020
PathoQuest and Charles River has established a U.S. subsidiary, PathoQuest and will construct a next generation sequencing-based testing laboratory at Charles River’s site in Wayne, PA.
read more
Friday, November 13, 2020
KDx has selected Acupath Laboratories to process urine specimens for a formal FDA trial that kicked off in Q3.
read more
Friday, September 04, 2020
SGS has announced the enrollment of the first patient into a new clinical trial designed to examine the safety, tolerability, and efficacy of a potential drug candidate for people suffering with COVID-19 related respiratory failure.
read more
Wednesday, August 05, 2020
Quest announced the FDA has granted EUA for a new laboratory technique that speeds the process of extracting viral RNA from specimens to expand its daily capacity of COVID-19 molecular diagnostic tests on behalf of patients.
read more
Octapharma and BioMatrix Specialty Pharmacy are supporting a new study focused on treating patients with COVID-19 and presenting with COVID-19-associated myocardial dysfunction.
read more